The prevalence and intensity of expression for the three master pluripotency markers (NANOG, SOX2, and OCT4) and ALDH1A1 in tumor tissue sections of the study participants is demonstrated in Figure 6, ranging from negative/mild to moderate/strong expressions. This evidence concerns the gene POU5F1 and neoplasm.